1. JNK, p38, ERK, and SGK1 Inhibitors in Cancer
   Jonas Cicenas et al, 2017, Cancers CrossRef
2. Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX
   Hye Eun Park et al, 2021, Scientific Reports CrossRef
3. Establishment and characterization of 18 human colorectal cancer cell lines
   Soon-Chan Kim et al, 2020, Scientific Reports CrossRef
4. The Importance of Being PI3K in the RAS Signaling Network
   Cristina Cuesta et al, 2021, Genes CrossRef
5. KRAS Oncogenic Signaling Extends beyond Cancer Cells to Orchestrate the Microenvironment
   Patrícia Dias Carvalho et al, 2018, Cancer Research CrossRef
6. Modulation of Fibroblast Phenotype by Colorectal Cancer Cell-Secreted Factors Is Mostly Independent of Oncogenic KRAS
   Patrícia Dias Carvalho et al, 2022, Cells CrossRef
7. Mediatory role of BLT2 in the proliferation of KRAS mutant colorectal cancer cells
   JaeIn Park et al, 2019, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
8. Protein phosphatase 6 promotes transforming growth factor-β signaling in mouse embryonic fibroblasts
   Nao KITAMURA et al, 2023, Journal of Veterinary Medical Science CrossRef
9. KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrix
   Jin K. Kim et al, 2021, Molecular Oncology CrossRef
10. Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer
    Sumi Yun et al, 2018, Cancer Research and Treatment CrossRef